 studi vancomycin versu teicoplanin treatment gram-posit bacteri infect immunocompromis host immunocompromis patient sever infect due gram-posit organ vancomycin teicoplanin extens cancer present patient month type infect bacteremia central cathet skin soft tissu infect bacteremia other bronchopneumonia frequent pathogen staphylococcu epidermidi staphylococcu aureu microbiolog erad evalu patient vancomycin patient teicoplanin clinic cure improv patient patient signific side effect teicoplanin contrast revers increas serum creatinin patient skin rash patient vancomycin superinfect patient vancomycin patient teicoplanin relat peak concentr serum steadi state bactericid titer outcom